Join us on LinkedIn for the latest news.

Upwards arrow: Go back to top
We use cookies to improve the user experience.
You can read more about our Cookie Policy here.
Accept

Latest & Greatest

Get to know the whole team, stay up to date and find out what drives us as successful life science enthusiasts and company builders.

follow us on linkedin
?
?

News & Press

Learn more about recent advances in biotech, health tech and our work.

See all press releases
Aeovian Pharmaceuticals Closes $50 Million Follow-On Round and Moves Towards Human Clinical TrialsAeovian Pharmaceuticals Closes $50 Million Follow-On Round and Moves Towards Human Clinical TrialsAeovian Pharmaceuticals Closes $50 Million Follow-On Round and Moves Towards Human Clinical Trials
28.3.24
Aeovian Pharmaceuticals Closes $50 Million Follow-On Round and Moves Towards Human Clinical Trials
Learn more
Download PDF
Learn more
Auron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its Novel AURIGIN™ PlatformAuron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its Novel AURIGIN™ PlatformAuron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its Novel AURIGIN™ Platform
8.2.24
Auron Selects First Development Candidate from its Novel AURIGIN™ Platform
Learn more
Download PDF
Learn more

Our Blog

Where we share what we are passionate about: insights from Apollo Health Ventures